Literature DB >> 11025437

Squamous cell carcinoma of the prostate without evidence of recurrence 5 years after operation.

M Imamura1, H Nishiyama, K Ohmori, K Nishimura.   

Abstract

A 54-year-old man underwent radical cystoprostatectomy after prostatic needle biopsy which revealed squamous cell carcinoma of the prostate. However, the positive surgical margin of the pubis suggested residual disease. He received chemotherapy with methotrexate, peplomycin and cisplatin (MPD regimen). He is at present still alive without evidence of recurrence 5 years after the operation. This suggests that MPD chemotherapy is effective for squamous cell carcinoma of the prostate. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11025437     DOI: 10.1159/000064853

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

1.  Squamous cell carcinoma of the prostate.

Authors:  Rena D Malik; George Dakwar; Matthew E Hardee; Nicholas J Sanfilippo; Andrew B Rosenkrantz; Samir S Taneja
Journal:  Rev Urol       Date:  2011

2.  Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation.

Authors:  Fernando Munoz; Pierfrancesco Franco; Patrizia Ciammella; Mario Clerico; Mauro Giudici; Andrea Riccardo Filippi; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2007-04-03       Impact factor: 3.481

3.  Fluorodeoxyglucose positron emission tomography/computed tomography imaging of a patient with squamous cell carcinoma of prostate.

Authors:  Gonca Kara Gedik; Guler Yavas; Murat Akand; Esin Celik; Oktay Sari
Journal:  Case Rep Med       Date:  2014-03-24

4.  Primary squamous cell carcinoma of the prostate: a case report of a rare clinical entity.

Authors:  Tithi Biswas; Tarun Podder; Pamela A Lepera; Paul Walker
Journal:  Future Sci OA       Date:  2015-11-01

5.  Squamous cell carcinoma of the prostate with SMARCA4 alteration in a Japanese patient.

Authors:  Yuta Kaneko; Takeo Kosaka; Kohei Nakamura; Shuji Mikami; Hiroshi Nishihara; Mototsugu Oya
Journal:  IJU Case Rep       Date:  2022-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.